Breno Santos Amaral

About

Dr. Breno Santos Amaral is a urologic oncologist whose research focuses on optimizing surgical outcomes and patient-reported quality of life in prostate and kidney cancer care. His major contributions include advancing the understanding of functional recovery after minimally invasive partial nephrectomy (MIPN), where he demonstrated how early postoperative estimated glomerular filtration rate (eGFR) can serve as a reliable predictor of optimal surgical success—work that has garnered over 6 citations. Dr. Amaral also led the psychometric validation of the Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP), a critical tool for assessing early functional outcomes after prostate cancer treatment. This culturally adapted instrument, cited 4 times, enables Brazilian clinicians to systematically capture urinary, bowel, sexual, and hormonal side effects in routine practice, bridging a gap in patient-centered care. By integrating rigorous methodology with practical clinical application, Dr. Amaral’s research empowers surgeons to better predict and manage post-treatment complications, ultimately improving long-term quality of life for urologic cancer patients.

Research Focus

Key Achievements

Top Papers

1. 1
   Optimal Surgical Outcome of Minimally Invasive Partial Nephrectomy (MIPN) Based on an Early Postoperative Estimated Glomerular Filtration Rate (eGFR)

   6 citations · 2021
2. 2
   Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution

   4 citations · 2020

Key Collaborators

Contact & Links